Basal cell carcinoma
Although basal cell carcinoma rarely metastasizes, it is still a serious disease. In North America, the median age of diagnosis is 40 years. It is more common in women than in men. It is obtained from epidermal stem cells and undifferentiated cells of the outer root sheath. Multiplicative risk factors include chronic UV exposure, a family history of sunburn, and occasional peak sun exposure.
The most common sites for basal cell carcinoma are the head and neck, the inner corner of the eye, the cheekbone, and the forehead. It is also possible to develop basal cell carcinoma on the ears, but these types are rare. Patients should seek treatment if they notice a nodule or ulcer. Symptoms include skin redness and crusting. In rare cases, the tumor may be a symptom of a more advanced form of the disease.
Although basal cell carcinoma is not a dangerous disease, doctors often prescribe radiation therapy to make the patient as comfortable as possible. The prospects for its healing are comparable to those of surgery. However, nowadays it is rarely used due to the better cosmetic results of microsurgical interventions. Recommended for patients with malignancy, primary inoperable, postoperative microscopic or macroscopic residual tumor, or postoperative recurrence of the condition. In addition to surgery, radiation therapy may be useful in treating recurrent basal cell carcinoma. You can find the latest developments in the field of cancer treatment on the medical website saludremediosar.com.